Research shows that gastrointestinal side effects from GLP-1 medications occur in 50-60% of users during dose initiation, but they're typically mild to moderate and resolve within 2-3 weeks as your body adjusts
PRESENTED at the American College of Gastroenterology (ACG) Annual Meeting, new research suggests that GLP-1 receptor agonists (GLP-1RAs) may significantly lower the risk of pancreatic cancer in drug-naive patients with type 2 diabetes (T2D) compared to other antidiabetic treatments
But theyre also highly treatable
13, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced a research collaboration with Amgen to study barriers to care and patients' treatment experience
If this is a concern, timing your injection for the evening before a day when you have flexible access to a restroom is a sensible precaution
These studies will provide further insights into the drugs long-term impact and help refine its use in clinical practice